These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 32558900

  • 1. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
    Sun X, Huang K, Haiming X, Lin Z, Yang Y, Zhang M, Liu P, Huang H.
    Clin Sci (Lond); 2020 Jul 17; 134(13):1573-1592. PubMed ID: 32558900
    [Abstract] [Full Text] [Related]

  • 2. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
    Zhang X, Liang D, Fan J, Lian X, Zhao Y, Wang X, Chi ZH, Zhang P.
    Biol Trace Elem Res; 2016 Oct 17; 173(2):372-83. PubMed ID: 26956696
    [Abstract] [Full Text] [Related]

  • 3. USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells.
    Sun XH, Xiao HM, Zhang M, Lin ZY, Yang Y, Chen R, Liu PQ, Huang KP, Huang HQ.
    Biochem Pharmacol; 2021 Jun 17; 188():114562. PubMed ID: 33857489
    [Abstract] [Full Text] [Related]

  • 4. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
    Du L, Qian X, Li Y, Li XZ, He LL, Xu L, Liu YQ, Li CC, Ma P, Shu FL, Lu Q, Yin XX.
    Acta Pharmacol Sin; 2021 Feb 17; 42(2):242-251. PubMed ID: 32555442
    [Abstract] [Full Text] [Related]

  • 5. Sirt1-hypoxia-inducible factor-1α interaction is a key mediator of tubulointerstitial damage in the aged kidney.
    Ryu DR, Yu MR, Kong KH, Kim H, Kwon SH, Jeon JS, Han DC, Noh H.
    Aging Cell; 2019 Apr 17; 18(2):e12904. PubMed ID: 30614190
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells.
    Tang L, Li H, Gou R, Cheng G, Guo Y, Fang Y, Chen F.
    Diabetes Res Clin Pract; 2014 Apr 17; 104(1):176-82. PubMed ID: 24447812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK, Park SH, Choi YJ, Shin D, Kang YH.
    J Mol Med (Berl); 2015 Jul 17; 93(7):759-72. PubMed ID: 26062793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway.
    Shao Y, Lv C, Wu C, Zhou Y, Wang Q.
    Diabetes Metab Res Rev; 2016 Sep 17; 32(6):534-43. PubMed ID: 26891083
    [Abstract] [Full Text] [Related]

  • 11. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L, Wang Y, Yan R, Liang L, Zhou X, Liu H, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Liu L, Shi M, Guo B.
    Life Sci; 2019 Dec 01; 238():116957. PubMed ID: 31655195
    [Abstract] [Full Text] [Related]

  • 12. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1.
    Zhao X, He X, Wei W, Huang K.
    Eur J Pharmacol; 2023 May 15; 947():175671. PubMed ID: 37001578
    [Abstract] [Full Text] [Related]

  • 13. Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice.
    Feng X, Wang S, Sun Z, Dong H, Yu H, Huang M, Gao X.
    Front Endocrinol (Lausanne); 2021 May 15; 12():626390. PubMed ID: 33679620
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes.
    Yang Y, Li J, Zhang L, Lin Z, Xiao H, Sun X, Zhang M, Liu P, Huang H.
    Pharmacol Res; 2021 Jan 15; 163():105333. PubMed ID: 33276097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Connexin32 ameliorates epithelial-to-mesenchymal-transition in diabetic renal tubular via inhibiting NOX4.
    Sun X, Xiao H, Li S, Chen R, Lin Z, Yang Y, Chen Z, Deng L, Huang H.
    Pharmacol Res; 2022 Feb 15; 176():106084. PubMed ID: 35051590
    [Abstract] [Full Text] [Related]

  • 18. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q, Ji XJ, Zhou YX, Yao XQ, Liu YQ, Zhang F, Yin XX.
    Pharmacol Res; 2015 Sep 15; 99():237-47. PubMed ID: 26151815
    [Abstract] [Full Text] [Related]

  • 19. Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis.
    Zeng J, Liang L, Chen R, Li C, Pan L, Wen M, Lv D, Liu M, Xu Z, Huang H.
    Eur J Pharmacol; 2023 Sep 15; 955():175915. PubMed ID: 37467841
    [Abstract] [Full Text] [Related]

  • 20. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
    Umino H, Hasegawa K, Minakuchi H, Muraoka H, Kawaguchi T, Kanda T, Tokuyama H, Wakino S, Itoh H.
    Sci Rep; 2018 May 01; 8(1):6791. PubMed ID: 29717156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.